IFNB1
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
IFNB1 |
---|
|
Available structures |
---|
PDB |
Ortholog search: PDBe RCSB
|
---|
|
|
Identifiers |
---|
Aliases |
IFNB1, IFB, IFF, IFNB, IFN-beta, interferon beta 1 |
---|
External IDs |
MGI: 107657 HomoloGene: 1640 GeneCards: IFNB1 |
---|
Gene location (Human) |
---|
| Chr. |
Chromosome 9 (human)[1] |
---|
| Band |
9p21.3 |
Start |
21,077,105 bp[1] |
---|
End |
21,077,963 bp[1] |
---|
|
Gene location (Mouse) |
---|
| Chr. |
Chromosome 4 (mouse)[2] |
---|
| Band |
4 C4|4 41.91 cM |
Start |
88,522,025 bp[2] |
---|
End |
88,522,774 bp[2] |
---|
|
RNA expression pattern |
---|
| More reference expression data |
|
Gene ontology |
---|
Molecular function |
• cytokine activity • cytokine receptor binding • chloramphenicol O-acetyltransferase activity • type I interferon receptor binding
|
---|
Cellular component |
• extracellular space • extracellular region
|
---|
Biological process |
• positive regulation of peptidyl-serine phosphorylation of STAT protein • blood coagulation • B cell differentiation • cellular response to interferon-beta • regulation of MHC class I biosynthetic process • negative regulation of viral genome replication • natural killer cell activation • B cell activation involved in immune response • positive regulation of apoptotic signaling pathway • cell surface receptor signaling pathway • natural killer cell activation involved in immune response • response to exogenous dsRNA • response to virus • T cell activation involved in immune response • positive regulation of transcription from RNA polymerase II promoter • defense response • negative regulation of T cell differentiation • positive regulation of innate immune response • cellular response to exogenous dsRNA • negative regulation of T-helper 2 cell cytokine production • defense response to virus • type I interferon signaling pathway • regulation of receptor activity • humoral immune response • B cell proliferation
|
---|
Sources:Amigo / QuickGO
|
|
Orthologs |
---|
Species |
Human |
Mouse |
---|
Entrez |
|
|
---|
Ensembl |
|
|
---|
UniProt |
|
|
---|
RefSeq (mRNA) |
|
|
---|
RefSeq (protein) |
|
|
---|
Location (UCSC) |
Chr 9: 21.08 – 21.08 Mb |
Chr 4: 88.52 – 88.52 Mb |
---|
PubMed search |
[3] |
[4] |
---|
Wikidata |
View/Edit Human |
View/Edit Mouse |
|
Interferon beta is a protein that in humans is encoded by the IFNB1 gene.[5] The natural and recombinant protein forms have antiviral, antibacterial, and anticancer properties.[6]
Interferon beta 1a (tradenames: Avonex and Rebif) and Interferon beta 1b (tradenames: Betaseron/Betaferon) are used as drugs.
References[edit]
^ abc GRCh38: Ensembl release 89: ENSG00000171855 - Ensembl, May 2017
^ abc GRCm38: Ensembl release 89: ENSMUSG00000048806 - Ensembl, May 2017
^ "Human PubMed Reference:"..mw-parser-output cite.citationfont-style:inherit.mw-parser-output qquotes:"""""""'""'".mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em
^ "Mouse PubMed Reference:".
^ "Entrez Gene: IFNB1 interferon, beta 1, fibroblast".
^ "IFNB1 recombinant protein".
{shfhfekg1215}
Further reading[edit]
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Biron CA, Nguyen KB, Pien GC (2002). "Innate immune responses to LCMV infections: natural killer cells and cytokines". Curr. Top. Microbiol. Immunol. 263: 7–27. doi:10.1007/978-3-642-56055-2_2. PMID 11987821.
Conti L, Fantuzzi L, Del Cornò M, et al. (2005). "Immunomodulatory effects of the HIV-1 gp120 protein on antigen presenting cells: implications for AIDS pathogenesis". Immunobiology. 209 (1–2): 99–115. doi:10.1016/j.imbio.2004.02.008. PMID 15481145.
Bekisz J, Schmeisser H, Hernandez J, et al. (2005). "Human interferons alpha, beta and omega". Growth Factors. 22 (4): 243–51. doi:10.1080/08977190400000833. PMID 15621727.
Copeland KF (2006). "Modulation of HIV-1 transcription by cytokines and chemokines". Mini Reviews in Medicinal Chemistry. 5 (12): 1093–101. doi:10.2174/138955705774933383. PMID 16375755.
Silverman RH, Sengupta DN (1991). "Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes". J. Exp. Pathol. 5 (2): 69–77. PMID 1708818.
Flores I, Mariano TM, Pestka S (1991). "Human interferon omega (omega) binds to the alpha/beta receptor". J. Biol. Chem. 266 (30): 19875–7. PMID 1834641.
May LT, Sehgal PB (1985). "On the relationship between human interferon alpha 1 and beta 1 genes". J. Interferon Res. 5 (3): 521–6. PMID 2414376.
Francois DT, Katona IM, June CH, et al. (1988). "Examination of the inhibitory and stimulatory effects of IFN-alpha, -beta, and -gamma on human B-cell proliferation induced by various B-cell mitogens". Clin. Immunol. Immunopathol. 48 (3): 297–306. doi:10.1016/0090-1229(88)90023-2. PMID 3135963.
Conradt HS, Egge H, Peter-Katalinic J, et al. (1987). "Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line". J. Biol. Chem. 262 (30): 14600–5. PMID 3667593.
Blank KJ, McKernan LN, Murasko DM (1985). "Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation". J. Interferon Res. 5 (1): 215–21. doi:10.1089/jir.1985.5.215. PMID 3872918.
Derynck R, Content J, DeClercq E, et al. (1980). "Isolation and structure of a human fibroblast interferon gene". Nature. 285 (5766): 542–7. doi:10.1038/285542a0. PMID 6157094.
Taniguchi T, Ohno S, Fujii-Kuriyama Y, Muramatsu M (1980). "The nucleotide sequence of human fibroblast interferon cDNA". Gene. 10 (1): 11–5. doi:10.1016/0378-1119(80)90138-9. PMID 6157601.
Houghton M, Easton MA, Stewart AG, et al. (1981). "The complete amino acid sequence of human fibroblast interferon as deduced using synthetic oligodeoxyribonucleotide primers of reverse transcriptase". Nucleic Acids Res. 8 (13): 2885–94. doi:10.1093/nar/8.13.2885. PMC 324132. PMID 6159580.
Goeddel DV, Shepard HM, Yelverton E, et al. (1981). "Synthesis of human fibroblast interferon by E. coli". Nucleic Acids Res. 8 (18): 4057–74. doi:10.1093/nar/8.18.4057. PMC 324219. PMID 6159584.
Houghton M, Stewart AG, Doel SM, et al. (1981). "The amino-terminal sequence of human fibroblast interferon as deduced from reverse transcripts obtained using synthetic oligonucleotide primers". Nucleic Acids Res. 8 (9): 1913–31. doi:10.1093/nar/8.9.1913. PMC 324047. PMID 6159597.
Wetzel R (1981). "Assignment of the disulphide bonds of leukocyte interferon". Nature. 289 (5798): 606–7. doi:10.1038/289606a0. PMID 6162107.
Lawn RM, Adelman J, Franke AE, et al. (1981). "Human fibroblast interferon gene lacks introns". Nucleic Acids Res. 9 (5): 1045–52. doi:10.1093/nar/9.5.1045. PMC 326735. PMID 6164984.
Shepard HM, Leung D, Stebbing N, Goeddel DV (1982). "A single amino acid change in IFN-beta1 abolishes its antiviral activity". Nature. 294 (5841): 563–5. doi:10.1038/294563a0. PMID 6171735.
Content J, De Wit L, Pierard D, et al. (1982). "Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta". Proc. Natl. Acad. Sci. U.S.A. 79 (9): 2768–72. doi:10.1073/pnas.79.9.2768. PMC 346287. PMID 6178110.
Fiers W, Remaut E, Devos R, et al. (1983). "The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells". Philos. Trans. R. Soc. Lond. B Biol. Sci. 299 (1094): 29–38. doi:10.1098/rstb.1982.0103. PMID 6183692.
jenfjw
PDB gallery
|
---|
@media all and (max-width:720px).mw-parser-output .mw-module-gallerydisplay:block!important;float:none!important.mw-parser-output .mw-module-gallery divdisplay:inherit!important;float:none!important;width:auto!important 1au1: HUMAN INTERFERON-BETA CRYSTAL STRUCTURE
|
Cell signaling: cytokines
|
---|
By family |
Chemokine |
CCL |
- CCL1
CCL2/MCP1
CCL3/MIP1α
CCL4/MIP1β
CCL5/RANTES
- CCL6
- CCL7
- CCL8
- CCL9
- CCL11
- CCL12
- CCL13
- CCL14
- CCL15
- CCL16
- CCL17
CCL18/PARC/DCCK1/AMAC1/MIP4
- CCL19
- CCL20
- CCL21
- CCL22
- CCL23
- CCL24
- CCL25
- CCL26
- CCL27
- CCL28
|
---|
CXCL |
CXCL1/KC
- CXCL2
- CXCL3
- CXCL4
- CXCL5
- CXCL6
- CXCL7
- CXCL8/IL8
- CXCL9
- CXCL10
- CXCL11
- CXCL12
- CXCL13
- CXCL14
- CXCL15
- CXCL16
- CXCL17
|
---|
CX3CL |
|
---|
XCL |
|
---|
|
---|
TNF |
- TNFA
Lymphotoxin
- TNFSF4
- TNFSF5/CD40LG
- TNFSF6
- TNFSF7
- TNFSF8
- TNFSF9
- TNFSF10
- TNFSF11
- TNFSF13
- TNFSF13B
- EDA
|
---|
Interleukin |
Type I (grouped by receptor subunit) |
γ chain |
IL2/IL15
IL4/IL13
- IL7
- IL9
- IL21
|
---|
β chain |
|
---|
IL6 like/gp130
|
|
---|
IL12 family/IL12RB1
|
|
---|
Other |
|
---|
|
---|
Type II |
IL10 family |
IL10/IL22
- IL19
- IL20
- IL24
- IL26
Interferon type III
|
---|
Interferon |
I |
- IFNA1
- IFNA2
- IFNA4
- IFNA5
- IFNA6
- IFNA7
- IFNA8
- IFNA10
- IFNA13
- IFNA14
- IFNA16
- IFNA17
- IFNA21
- IFNB1
- IFNK
- IFNW1
|
---|
II |
|
---|
|
---|
|
---|
Ig superfamily |
IL1 family: IL1A/IL1F1
- IL1B/IL1F2
- 1Ra/IL1F3
- IL1F5
- IL1F6
- IL1F7
- IL1F8
- IL1F9
- IL1F10
- 33/IL1F11
- 18/IL1G
|
---|
IL17 family |
|
---|
|
---|
Other |
Hematopoietic
- KITLG
- Colony-stimulating factor
- SPP1
- MIF
|
---|
|
---|
By function/ cell |
|
---|
Cytokine receptor modulators
|
---|
Chemokine |
|
---|
CSF |
Erythropoietin |
Agonists: ARA-290
- Asialo erythropoietin
- Carbamylated erythropoietin
- CNTO-530
- Darbepoetin alfa
- Epoetin alfa
- Epoetin beta
- Epoetin delta
- Epoetin epsilon
- Epoetin gamma
- Epoetin kappa
- Epoetin omega
- Epoetin theta
- Epoetin zeta
- Erythropoietin (EPO)
- Erythropoietin-Fc
- Methoxy polyethylene glycol-epoetin beta (CERA/Mircera)
- Peginesatide
- Pegol sihematide (EPO-018B)
|
---|
G-CSF (CSF3) |
Agonists: Filgrastim
- Granulocyte colony-stimulating factor
- Lenograstim
- Leridistim
- Lipegfilgrastim
- Nartograstim
- Pegfilgrastim
- Pegnartograstim
|
---|
GM-CSF (CSF2) |
Agonists: Ecogramostim
- Granulocyte macrophage colony-stimulating factor
- Milodistim
- Molgramostim
- Regramostim
- Sargramostim
Antibodies: Mavrilimumab
- MOR103
- Namilumab
|
---|
M-CSF (CSF1) |
Agonists: Cilmostim
- Interleukin-34
- Lanimostim
- Macrophage colony-stimulating factor
- Mirimostim
Kinase inhibitors: Agerafenib
|
---|
SCF (c-Kit) |
|
---|
Thrombopoietin |
Agonists: Eltrombopag
- Pegacaristim
- Promegapoietin
- Romiplostim
- Thrombopoietin (THPO, MGDF)
|
---|
|
---|
Interferon |
IFNAR (α/β, I) |
Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
Antibodies: Anifrolumab
- Faralimomab
- MEDI-545
- Rontalizumab
- Sifalimumab
Decoy receptors: Bifarcept
|
---|
IFNGR (γ, II) |
Agonists: Interferon gamma (IFN-γ)
- Interferon gamma 1b
Antibodies: Emapalumab
- Fontolizumab
|
---|
IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
---|
|
---|
Interleukin |
|
---|
TGFβ |
|
---|
TNF |
|
---|
Others |
JAK (inhibitors)
|
JAK1 |
- Baricitinib
- Filgotinib
- Momelotinib
- Oclacitinib
- Ruxolitinib
- Tofacitinib (tasocitinib, CP-690550)
- Upadacitinib
|
---|
JAK2 |
- AG-490
- Atiprimod
- AZD-1480
- Baricitinib
- CHZ868
- Cucurbitacin I (elatericin B, JSI-124)
- CYT387
- Lestaurtinib
- NSC-7908
- NSC-33994
- Pacritinib
- Ruxolitinib
- SD-1008
- Tofacitinib (tasocitinib, CP-690550)
|
---|
JAK3 |
- AG-490
- Cercosporamide
- TCS-21311
- Tofacitinib (tasocitinib, CP-690550)
- WHI-P 154
- ZM-39923
- ZM-449829
|
---|
|
---|
Others |
Additional cytokines: Cardiotrophin 1 (CT-1)
- FMS-like tyrosine kinase 3 ligand (FLT3L)
- Leukemia/leukocyte inhibitory factor (LIF)
- Oncostatin M (OSM)
- Thymic stromal lymphopoietin (TSLP)
Additional cytokine receptor modulators: Emfilermin
- Lestaurtinib
- Midostaurin
- Quizartinib
- Sorafenib
- Sunitinib
|
---|
|
---|
- See also
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Growth factor receptor modulators
|
Categories:
- Genes on human chromosome 9
- Human chromosome 9 gene stubs
Navigation menu
Personal tools
- Not logged in
- Talk
- Contributions
- Create account
- Log in
Navigation
- Main page
- Contents
- Featured content
- Current events
- Random article
- Donate to Wikipedia
- Wikipedia store
Interaction
- Help
- About Wikipedia
- Community portal
- Recent changes
- Contact page
Tools
- What links here
- Related changes
- Upload file
- Special pages
- Permanent link
- Page information
- Wikidata item
- Cite this page
Print/export
- Create a book
- Download as PDF
- Printable version
(window.RLQ=window.RLQ||).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.740","walltime":"0.875","ppvisitednodes":"value":1543,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":238004,"limit":2097152,"templateargumentsize":"value":20039,"limit":2097152,"expansiondepth":"value":11,"limit":40,"expensivefunctioncount":"value":38,"limit":500,"unstrip-depth":"value":1,"limit":20,"unstrip-size":"value":43193,"limit":5000000,"entityaccesscount":"value":39,"limit":400,"timingprofile":["100.00% 669.613 1 -total"," 58.86% 394.103 1 Template:Infobox_gene"," 22.27% 149.109 1 Template:PBB_Further_reading"," 21.87% 146.472 20 Template:Cite_journal"," 14.90% 99.766 13 Template:Navbox"," 4.30% 28.781 1 Template:Reflist"," 3.35% 22.464 1 Template:PDB_Gallery"," 3.21% 21.488 1 Template:Cytokines"," 2.96% 19.839 1 Template:Cytokine_receptor_modulators"," 2.02% 13.533 1 Template:Refbegin"],"scribunto":"limitreport-timeusage":"value":"0.491","limit":"10.000","limitreport-memusage":"value":6784251,"limit":52428800,"cachereport":"origin":"mw1258","timestamp":"20181012044143","ttl":1900800,"transientcontent":false);mw.config.set("wgBackendResponseTime":83,"wgHostname":"mw1327"););